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Abstract 25 
Metabolic enzymes show a high degree of redundancy, and for that reason they are generally 26 
ignored when searching for novel targets for anti-infective substances. The enzymes PurN and 27 
PurT are redundant in vitro in Salmonella enterica serovar Typhimurium (S. Typhimurium), where 28 
they perform the third step in the purine synthesis. Surprisingly the results of the current study 29 
demonstrated that single gene deletions of each of the genes encoding these enzymes caused 30 
attenuation (competitive infection index < 0.03) in mouse infections. While the ΔpurT mutant 31 
multiplied as fast as the wild type strain in cultured J774A.1 macrophages, net multiplication of the 32 
ΔpurN mutant was reduced by approximately 50 % in 20 hours. The attenuation of the ΔpurT 33 
mutant was abolished by simultaneous removal of the enzyme PurU, responsible for formation of 34 
formate, indicating that the attenuation was related to formate accumulation or wasteful 35 
consumption of formyl-tetrahydrofolate by PurU. In the process of further characterization, we 36 
disclosed that in vivo the enzyme-complex GCV was the most important for formation of C-1 units 37 
in vivo (CI: 0.03 ± 0.03). In contrast, GlyA was the only important enzyme for the formation of C-38 
1 units in vitro. The results with the ΔgcvT mutant further revealed that formation of serine by 39 
SerA and further conversion of serine into C-1 units and glycine by GlyA was not sufficient to 40 
ensure C-1 formation in S. Typhimurium in vivo. The study calls for re-investigations of the 41 
concept of metabolic redundancy in S. Typhimurium in vivo. 42 
  43 
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Introduction 44 
Salmonella enterica is a common cause of food borne disease worldwide. Annually, more than 93 45 
million people have been estimated to suffer from non-Typhoid salmonellosis, and more than 46 
155.000 people succumb to the disease (1). Infection with the serovar S. Typhimurium in mice 47 
does not cause diarrhoea, but results in a systemic, life-threatening condition, where bacteria 48 
predominantly localize in cells of the immune system in the liver and spleen. For this reason, S. 49 
Typhimurium infection of mice is used as a model for systemic salmonellosis, including infection 50 
with the host-specific serovar S. Typhi (2).  51 
 52 
The diversity of intra-cellular and extra-cellular host-niches occupied by S. Typhimurium is 53 
reflected in a high-degree of metabolic flexibility (3). This flexibility is achieved through component 54 
and systems-level redundancy in the metabolic network (4), and recent years have seen several 55 
studies of S. Typhimurium in order to understand the importance of metabolic redundancy for its 56 
pathogenic life style (5-8). These studies have used genome scale metabolic modelling to predict 57 
essential and combined-lethal metabolic reactions; the latter group consists of two or more non-58 
essential reactions, which, when considered as one unit, are found to be essential. Such 59 
combinations are referred to as minimal cut-sets in metabolic modelling (9). 60 
 61 
A list of 102 cut-sets of metabolic reactions in S. Typhimurium was recently produced using a 62 
novel genome-scale metabolic model. Each cut-set was predicted to be essential for growth in a 63 
modified M9-minimal medium, and the underlying assumption was that blocking such 64 
combinations of reactions would attenuate S. Typhimurium during infection. One cut-set was the 65 
combination of reactions carried out by the enzymes PurN (glycineamide-ribonuclease-66 
transformylase-N) and PurT (glycineamide-ribonuclease-transformylase-T) in the purine 67 
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biosynthesis pathway (8). A study using a similar approach by Thiele et al. (5) also predicted that 68 
combined blocking of PurN and PurT would be detrimental to growth.  69 
 70 
Purine de novo synthesis consists of ten steps, converting phosporibosyl-pyrophosphate (PRPP) 71 
into inosine-monophosphate (IMP) (10). In protobacteria the third step, which converts 5´-72 
phosphoribosyl-glycineamide (GAR) into formyl-phosphoribosyl-glycinamide (fGAR), is carried out 73 
by the two enzymes in the predicted cut-set, PurN and PurT, using different formyl donors. 74 
Blockage of this step results in accumulation of GAR and depletion of all down-stream products, 75 
why it is considered essential for the purine synthesis (11). The reactions carried out by PurN 76 
(GART-RXN) and PurT (GARTRASFORMYL2-RXN) are thus textbook examples of functional 77 
redundancy in metabolic reactions, and the prediction as a cut-set in S. Typhimurium was not 78 
surprising.  79 
 80 
PurN and PurT are not isoenzymes because PurN, which is found in both prokaryotes and 81 
eukaryotes (10,12), obtains the formyl-group for generation of fGAR from formyl-tetrahydrofolate 82 
(fTHF), while the prokaryote-specific enzyme PurT uses formate (13) (Fig 1A). As seen in Fig 1B, 83 
PurN and PurT create a link between purine synthesis and the folate Carbon-1 (C-1) metabolism, 84 
where essential C-1 units are formed (14). Aside from delivering carbon-2 and carbon-8 in purine 85 
synthesis, the folate metabolism delivers methyl-groups for the amino acid methionine and the 86 
deoxynucleotide dTMP. PurT is unique in that it uses formate as C-1 donor. Under anaerobic 87 
conditions formate is formed from pyruvate in the oxygen sensitive pyruvate formate lyase (PFL) 88 
reaction (15), but under aerobic conditions, formate is solely derived from fTHF in a reaction 89 
catalysed by the PurU enzyme (16) (Fig 1A). If the PurT enzyme does not use formate, it is a 90 
dead-end product in aerobic metabolism, and it cannot be fuelled back into the C-1 metabolism 91 
(17). Like in E. coli (14,18), C-1 units for amino acid and purine synthesis are produced by the 92 
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GlyA reaction during conversion of serine into glycine, and from degradation of glycine to ammonia 93 
and carbon dioxide by the glycine cleavage system (GCV) (Fig 1B).  94 
 95 
Mutants that lack purN or purT, or both genes, have been constructed and characterized in E. coli 96 
(11). purN and purT mutants grew slightly slower than their parental strains in minimal medium 97 
under both aerobic and anaerobic conditions. Interestingly, growth of the purN mutants was 98 
inhibited by addition of glycine under aerobic, but not under anaerobic conditions, suggesting that 99 
the effect of glycine was due to limiting formate production. A kinetic analysis of the purified PurU 100 
enzyme offered an explanation for this phenomenon, as its hydrolase activity was severely 101 
inhibited by glycine (18). In the purN mutant, glycine inhibition of formate production by PurU thus 102 
prevented fGAR synthesis by PurT. When the authors found the PurU activity to be activated also 103 
by histidine, they proposed that the PurU enzyme functions as a regulator that balances the folate 104 
intermediates tetrahydrofolate (THF), methylene tetrahydrofolate (mTHF), and formyl 105 
tetrahydrofolate (fTHF) as a function of the glycine and methionine concentrations.  106 
 107 
Currently we lack good knowledge on the in vivo metabolism (in the host) of pathogenic bacteria, 108 
even though this arguably is just as important as virulence factors for the ability of the pathogenic 109 
bacterium to carry out the infection (19). This included lack of knowledge on which nutrients the 110 
bacteria can scavenge from the host, which metabolites different bacteria needs to synthesize and 111 
how this differs between different bacteria, different hosts and even different places the bacterium 112 
occupies in the same host during infection. In the absence of experimental data, we rely on 113 
deduction from their in vitro (laboratory) growth phenotypes and model simulations. In some 114 
situations we observe good correlations between in vitro and in vivo phenotypes with respect to 115 
prediction of the ability to carry out the infection (8), but sometimes this is not the case, probably 116 
because functional auxotrophy may arise when metabolites are present in levels below an 117 
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important threshold during infection of the host, resulting in unforeseen regulatory effects. Under 118 
such conditions, predicted redundant reactions may turn out to be non-redundant. In the current 119 
study, we show that the universally acknowledged redundant enzyme-pair, PurN/PurT does not 120 
show functional redundancy in S. Typhimurium during infection of mice. Rather, each enzyme is by 121 
itself essential for infection. Likewise the redundant enzyme pair MetE/MetH was shown to be non-122 
redundant during mouse infection. An important message from this study is that well-established 123 
pairs of redundant enzymes may be functionally non-redundant in vivo and cannot a priori be 124 
classified as redundant based upon metabolic modelling. So there is a dire need to reinvestigate 125 
the concept of metabolic redundancy in Salmonella and other pathogenic bacteria in the in vivo 126 
situation.  127 
 128 
Material and Methods 129 
 130 
Bacterial strains 131 
S. Typhimurium 4/74 was used as wild-type strain and for the construction of mutant strains by 132 
lambda red mediated re-combination (20), essentially as previously described (8) (Table 1). 133 
Mutated alleles were transformed to a clean wild type S. Typhimurium 4/74 background by 134 
P22HT105/int-20 mediated transduction, as described (8). Transduction was also used to construct 135 
double and triple mutants. For construction of triple mutants, the resistance marker, normally 136 
kanamycin, was flipped out using the FLT system as described (20), while each gene contained a 137 
different antibiotic cassette in the double mutants. Primers for mutant construction are listed in 138 
Supplementary Material, Table S1, together with primers used to control the mutations, generally 139 
by two PCR-reactions, one targeting the inserted antibiotic resistance gene and the flanking 140 
regions of the desired genes and one targeting both flanking regions. 141 
 142 
 o
n
 June 8, 2016 by TECH KNO
W
LEDG
E CTR O
F DENM
ARK
http://iai.asm
.org/
D
ow
nloaded from
 
  7
Genetic complementation was obtained by PCR-amplification of the relevant gene and subsequent 143 
cloning into the low copy number plasmid pACYC177, followed by transformation of the resulting 144 
plasmid into the mutant strain, essentially as described (21). Primers are listed in Supplementary 145 
Material, Table S1. Restriction enzymes XhoI and BamHI were used for cloning according to the 146 
manufacturer´s recommendation (Thermo Scientific, by, Denmark), and constructs were verified 147 
by restriction analysis and sequence analysis. 148 
 149 
Culture and growth conditions 150 
Growth of bacteria in rich media was done in DifcoTM Lysogeny broth, Lennox (Becton, Dickinson 151 
and Company, Albertslund, Denmark) and on LB agar plates (Becton, Dickinson and Company, 152 
Albertslund, Denmark), and growth in minimal medium was carried out in M9-broth (2 mM MgSO4, 153 
0.1 mM CaCl2, 0.4 % glucose, 8.5 mM NaCl, 42 mM Na2HPO4, 22 mM KH2PO4, 18.6 mM NH4Cl). 154 
Chloramphenicol 10 ug/ml, kanamycin 50 ug/ml, glycine 0.55 mg/ml, serine 0.55 mg/ml and 155 
methionine 0.55 mg/ml (Sigma, Denmark), were added when appropriate.  156 
 157 
Growth phenotypes of mutants were determined by first growing the bacterium overnight in LB 158 
flasks at 37 °C with shaking (200 rpm). This culture was diluted 40 fold into 0.2 ml M9 and growth 159 
was followed for 24 hours at 37 °c with shaking (250 rpm) by OD600 measurement each 15 160 
minutes in a BioScreen CTM format with biological triplicates and technical replicates. Wild type 161 
strain and blank wells were included as controls. Growth curves were extracted using Excel 162 
(Microsoft, SanDiego, USA) and OD600 values were corrected for the blank controls.  163 
 164 
Microscopic appearance of bacteria 165 
The microscopic appearance of bacteria was determined by phase contrast microscopy at fixed 166 
time points and conditions using an AxioCamHR4 phase-contrast microscope. Three hundred 167 
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individual cells were observed to determine the most common cell morphology. Continuous 168 
observations of cell morphology during growth in LB media at 37 °C was done using oCelloScope 169 
bright field camera (magnification of approximately 200x and resolution of 1.3 µm) as reported 170 
(22). 171 
  172 
Macrophage survival experiments  173 
Survival and multiplication inside J774 macrophages were measured as described (21). S. 174 
Typhimurium 4/74 was used as reference wild type, and ΔssaV mutant in the 4/74 background 175 
(21) was used as negative control. Deletion of this gene renders S. Typhimurium incapable of intra 176 
cellular replication (23). Briefly, MOI of infection was 5 and 25 minutes was allowed for the initial 177 
uptake of bacteria, whereafter gentamicin (100 ug/ml) was added for one hour and then replaced 178 
with 25 ug/ml for the rest of the experiments. CFU counts with three or four biological repeats and 179 
with technical duplicates were obtained at the point of the first addition of gentamicin, and after 1 180 
hour, 2 hours and 21 hours of incubation with this drug.   181 
 182 
Mouse infections 183 
Measurement of infection efficacy was performed using a systemic model of infection in C57/BL6 184 
female mice (Taconic, Denmark). The competitive challenge model (24) where wild type and 185 
mutant strain were given together in the same mouse was used, as described (8). Briefly, mice 186 
were inoculated by the I.P. route with 0.1 ml of an approximately 1:1 mixture of wild type and 187 
mutant strains in PBS. The inoculum was standardized to contain a challenge dose of 5×103 188 
bacteria of each strain using CFU measurements. The exact amount of each strain in the inoculum 189 
was determined by plating serial dilutions on LB plates. The ratio between wild type and mutant 190 
bacteria in the spleen was determined 6 days post-inoculation by plating dilution series on LB agar 191 
and subsequently determining the resistance (chloramphenicol or kanamycin resistance) of 100 192 
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colonies. Sensitive bacteria corresponded to wild type and resistant bacteria to mutants. The 193 
competitive index was calculated as the mutant/wild type ratio of the spleen count versus the 194 
mutant/wild type ratio of the inoculum. Severely affected mice were humanely killed. If the spleen 195 
of such mice contained >105 CFU Salmonella this was expected to be the cause of the disease, and 196 
colony counts of such mice were included in the competitive index scoring.  197 
 198 
Ethical statement 199 
Mice challenge experiments were conducted with permission to the senior author from the Danish 200 
Animal Experiments Inspectorate according to Danish by-law No. 474 of 15th May 2014 (license 201 
number: 2009/561–1675).  202 
 203 
Statistical analysis 204 
Statistical differences between wild type and mutant strains in CFU, and in virulence measured in 205 
mice, was determined using GraphPad Prism®, version 5.0 (GraphPad software, Town, USA) with 206 
one-sample t-test analysis. Grubb´s outlier test was performed to exclude outliers with a 207 
significance of 0.05. 208 
 209 
Results 210 
 211 
PurN and PurT are redundant in vitro but not in vivo. 212 
PurN and PurT have been reported to be redundant for growth of E. coli, although purN and purT 213 
mutants grow somewhat slower than the wild type (11). Single mutants in S. Typhimurium 4/74 214 
created by deletion of the purN and purT genes grew as well as the parental wild type strain in 215 
minimal medium (WT: μ= 0.37±0.017, ΔpurN: μ= 0.35±0.01 and ΔpurT: μ= 0.36±0.02), while 216 
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the double mutant did not grow. The growth determination of the ΔpurN mutant is shown in 217 
Supplementary Figure S1 to demonstrate the way specific growth grates were determined. When 218 
grown in rich media (LB), the double mutant had no growth defect (data not shown). This 219 
corresponds to PurN and PurT being redundant for growth in minimal medium in vitro. 220 
 221 
When the mutants were analysed for their virulence in mice, using competitive challenging 222 
experiments, both single and double mutants were severely attenuated, showing competitive 223 
indexes (CIs) below 0.03. Virulence of single mutants could be raised to normal levels by 224 
complementation with wild type genes in trans (Table 2), showing that the attenuation was due to 225 
lack of PurN and PurT, respectively. Thus, in the infection situation, one or more factors are 226 
limiting for growth in an enzyme-specific manner for the presumed redundant enzyme-pair 227 
PurN/PurT, clearly showing that they are not redundant in vivo during infection of mice.  228 
 229 
Mutation of purN but not purT attenuates the strain during interaction with 230 
cultured macrophages. 231 
Interaction with macrophages is an important step in the development of systemic salmonellosis in 232 
mice, and the majority of mutants that fail to grow in cultured macrophages have turned out to be 233 
attenuated during mice infection (25). To investigate the ability to grow in macrophages, we 234 
challenged cultured J774A.1 macrophages with ΔpurN and ΔpurT mutants. As seen in Table 2, the 235 
WT strain was found to multiply 9.7± 2.5 times in 20 hours. This equals approximately seven-hour 236 
generation time, and corresponds to estimates for multiplication of S. Typhimurium in the spleen 237 
of mice in vivo (26).  In contrast, the ΔpurN mutant only multiplied 4.4 ± 3.5 times, which was 238 
significantly less than the wild type strain (p=0.03). The ΔpurT mutant resembled the wild type 239 
strain and multiplied 8.0 ± 5.6 times, suggesting that the attenuation in virulence caused by the 240 
deletion of purT was not related to interaction at the macrophage level, while attenuation of the 241 
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ΔpurN mutant might be related to replication in cells of this type. The double mutant was severely 242 
attenuated, and the resulting number of bacteria after 20 hours was reduced 70% compared to 243 
the number of cells taken up by the macrophages (Table 2). The control strain, S. Typhimurium 244 
4/74 lacking ssaV, encoding an effector protein of the type three secretion system, SPI-2, 245 
associated with intracellular multiplication (23), multiplied 2.1 ± 0.6 times, which was within the 246 
expected range, showing that the assay was performing as expected. The differences in 247 
multiplication were not caused by different starting concentrations, since all strains were taken up 248 
by the macrophages to the same degree (data not shown). 249 
 250 
Cooperation between PurT and PurU in vitro, in macrophages and during mouse 251 
infection 252 
 253 
Conversion of GAR to fGAR by the PurT enzyme requires free formate, provided by PurU (16). If 254 
the attenuation caused by deletion of purT was related to accumulation of formate, then deletion 255 
of purU in a ΔpurT background should eliminate the attenuation.  256 
 257 
Contrary to ΔpurT, a ΔpurU mutant showed no growth defect in E. coli (16). Interestingly, the 258 
opposite was observed in S. Typhimurium. The ΔpurT mutant was not growth arrested, whereas a 259 
purU deletion in S. Typhimurium strain 4/74 resulted in a reduced growth in M9 minimal medium 260 
(μ= 0.25±0.002; p-value compared to WT strain <0.05). Complementation by providing the purU 261 
gene in trans did not restore wild type growth; on the contrary, it reduced growth rate further (μ= 262 
0.15±0.002) (Table 2). A possible explanation is that provision of PurU in trans on a plasmid 263 
results in too high enzyme levels and excessive conversion of fTHF into THF and formate. A purT 264 
deletion in the ΔpurU mutant restored normal growth (μ= 0.38±0.01). This showed that the slow 265 
growth rate of a ΔpurU mutant was not related to lack of substrate for PurT, and that the growth 266 
 o
n
 June 8, 2016 by TECH KNO
W
LEDG
E CTR O
F DENM
ARK
http://iai.asm
.org/
D
ow
nloaded from
 
  12
attenuation of the ΔpurT mutant probably was caused by formate accumulation or wasteful 267 
conversion of fTHF to THF, which disappears when PurT and PurU are absent in the same 268 
bacterium. 269 
 270 
In macrophage experiments the ΔpurU mutant was significantly attenuated in multiplication over 271 
20 hours (4.6 ± 2.5; p<0.05). The ΔpurU mutant was also significantly attenuated in mouse 272 
virulence, albeit not to a level that resembled ΔpurN and ΔpurT mutants (Table 2). In accordance 273 
with the phenotype seen during growth in M9 medium, a completely restored virulence of the 274 
ΔpurT/ΔpurU double mutant was seen in the mice assay (CI: 1.6) (Table 2).  275 
 276 
Glycine but not serine is available for C-1 production during mouse infection  277 
Purine and C-1 metabolism are closely linked, and the reason that PurN and PurT are not 278 
functionally redundant in vivo during infection of mice could be related to the need to secure 279 
sufficient purine synthesis and C-1 metabolism to occur concurrently. Detailed investigations of the 280 
role of C-1 metabolism of S. Typhimurium in virulence have not been reported, and we therefore 281 
undertook a series of characterizations of mutants in the S. Typhimurium serine and glycine 282 
metabolism.  283 
 284 
We have previously predicted and validated by challenge experiments that a ΔserA mutant, which 285 
is unable to synthesize serine and therefore rely on uptake of serine or production of serine from 286 
glycine for serine production (see Fig 1B), is fully virulent in mice (8). Others have likewise 287 
predicted by in silico modelling that SerA is not needed for growth in vivo (5). From this we 288 
previously concluded that serine was most likely taken up from the host environment, but that 289 
further studies were needed to understand the relative contribution of GlyA and the glycine 290 
cleavage enzyme, GVC, in the phenotype of the ΔserA mutant (8). In the present study we 291 
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analysed a ΔgcvT mutation that cannot convert glycine into C-1 units and CO2 (see Fig 1B). 292 
Whether the ΔgcvT mutation was present alone or together with the ΔserA mutation, virulence 293 
was reduced significantly. The strain multiplied like the wild type strain in cultured macrophages, 294 
suggesting that the limiting step in infection was not intracellular multiplication in this cell type 295 
(Table 3). The results show that exogenous glycine, and not serine as previously believed, was 296 
available during infection. If serine had been available in sufficient amounts for synthesis of glycine 297 
and C-1 units, then the ΔgcvT mutation would have had no effect. This appears to be the situation 298 
in vitro, since the ΔgcvT mutant grew as well as the wild type strain in M9 medium (μ= 299 
0.31±0.21), while the ΔglyA mutant was severely growth attenuated. This phenotype could be 300 
reversed by addition of the wild type glyA gene in trans, and addition of glycine to the minimal 301 
medium also restored growth partially (Table 3). The wild type 4/74 strain was not affected by 302 
addition of glycine to the medium (data not shown). These observations suggest that in vitro GlyA 303 
is the enzyme that is most important for production of C-1 units, while the glycine cleave system 304 
has this role in vivo, and it underscores the difficulty in predicting in vivo importance from in vitro 305 
growth phenotypes. We can also conclude from the ΔgcvT single mutant, that serine production 306 
through the SerA enzyme (present in the ΔgcvT single mutant) and subsequent conversion to 307 
glycine and C-1 units by the GlyA enzyme (also present) is not sufficient to support virulence of 308 
Salmonella Typhimurium 4/74 in the mouse model.  309 
 310 
These conclusions were corroborated by the analysis of the ΔglyA mutant, which was only partly 311 
reduced in virulence (Table 3). If glycine were normally synthesized from serine through the GlyA 312 
enzyme, then the mutation would have had severe consequences. As expected, the introduction of 313 
a ΔserA mutation (in itself dispensable) in the ΔglyA strain (partly avirulent) resulted in total 314 
avirulence, because now the cell had no means of obtaining serine for protein synthesis. For the 315 
same reason, Thiele et al. (5) predicted this combination to be lethal in S. Typhimurium. Deletion 316 
 o
n
 June 8, 2016 by TECH KNO
W
LEDG
E CTR O
F DENM
ARK
http://iai.asm
.org/
D
ow
nloaded from
 
  14
of the gcvT gene in the ΔglyA background increased attenuation even further than the two single 317 
mutations, and no colonies were obtained from mice challenged with this strain. If for statistical 318 
purposes one assumed one colony per mice, this would not have been significantly different from 319 
the ΔgcvT mutant on its own, but significantly more attenuated than the ΔglyA mutant (Table 3). 320 
The observation was expected, because now the production of C-1 units for purine and methionine 321 
synthesis was totally blocked.  In macrophages, growth of the ΔglyA mutant was highly impaired, 322 
and a wild-type glyA gene provided in trans complemented this phenotype (Table 3), suggesting 323 
that either glycine biosynthesis or formation of serine from glycine was a limiting factor for S. 324 
Typhimurium growth in macrophages, but also that the lower multiplication rate does not lead to 325 
total avirulence in mice (CI: 0.3). 326 
 327 
The results with the glyA mutant to some extend contradicted a previous report by us (8), where 328 
we concluded that the ΔglyA deletion mutant was more attenuated in mice than reported here. 329 
Upon microscopic analysis of the different mutants we discovered a possible reason for this 330 
discrepancy. The ΔglyA deletion, and deletion of glyA in combination with gcvT, resulted in a 331 
mixture of normally shaped and elongated bacteria (Supplementary material Fig S2. The altered 332 
relation between the optical density and the concentration of colony forming units of the ΔglyA 333 
mutant cultures may have led us to the overestimation of the importance in virulence in the 334 
previous study where we used OD-values to prepare the inoculum, because the elongated cells 335 
resulted in a lower mutant-to-wild type ratio in the input pool. In the present study, the infections 336 
were performed with a one-to-one ratio based upon number of colony forming units, eliminating 337 
this problem. Elongation of cells could be eliminated by complementation in trans (data not 338 
shown), showing that the cell division was somehow affected by elimination of the GlyA reaction. 339 
We did not enquire further into this interesting phenotype in the present study.  340 
 341 
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We showed above that virulence attenuation of the ΔpurT mutant was probably associated to 342 
imbalance in formate or fTHF conversion. To investigate whether lack of THF production affected 343 
the phenotype of mutants in C-1-metabolism, we characterized a number of combined purine 344 
synthesis and C-1 metabolism mutants. All four combinations of ΔserA or ΔglyA mutations with 345 
mutation in purN and purT were growth attenuated to the same extend as the single ΔserA or 346 
ΔglyA mutants in vitro (combinations with ΔpurN: μ= 0.00 (ΔserA) and 0.04 ± 0.003 (ΔglyA); 347 
combinations with ΔpurT; μ= 0.00 (ΔserA) and 0.03 ± 0.00 (ΔglyA)). From this we concluded that 348 
there was no significant effect of the extra deletion of purN and purT in the ΔserA and ΔglyA 349 
mutants in vitro  even though the competing use of methylene-THF for purine biosynthesis was 350 
prevented.  We also tested the ΔpurN/ΔglyA strain in the mouse model and this strain was not 351 
significantly different from the ΔpurN mutant on its own (CI: 0.02±0.02), while the ΔpurT/ΔserA  352 
mutant apparently was less attenuated than the ΔpurT strain (CI:0.17±0.13), however the 353 
difference was not statistically different from the ΔpurT strain on its own (p>0.05). Together these 354 
experiments indicated little or no overlap between the two systems.  355 
 356 
Synthesis of methionine from homocysteine and C1-THF in vivo.   357 
Methionine synthesis is also interlinked with the purine synthesis through the common pool of 358 
mTHF and THF (Fig 1B), and we therefore also considered its importance for the results obtained 359 
with S. Typhimurium lacking PurN or PurT. Methionine is synthesized by two homocysteine 360 
methylating enzymes, MetE and MetH (27). The apparent redundancy of the reaction should 361 
enable the strain to synthesize methionine even when either the metE or the metH gene was 362 
mutated, and previous predictions of redundancy in S. Typhimurium has predicted that these two 363 
enzymes form a cut-set (6). However, while the MetE enzyme is functional under aerobic growth, 364 
the MetH enzyme requires vitamin B12, which is only synthesized in S. Typhimurium under 365 
anaerobic conditions (28). The ΔmetE mutant was found to be highly growth retarded (μ= 366 
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0.09±0.03), most probably because the bacterium then relies on the anaerobic enzyme, MetH. 367 
Interestingly, however, also a ΔmetH mutant was found to grow with a lower growth rate than the 368 
wild type in M9 medium (μ= 0.20±0.01), suggesting that the MetH enzyme is important under the 369 
growth condition tested (Table 4). As expected, a ΔmetE/ΔmetH double mutant did not grow in 370 
M9 minimal medium, since no methionine is available to this strain for protein synthesis. This 371 
phenotype could be complemented by addition of methionine to the medium (μ= 0.31±0.02), a 372 
step that did not affect growth of the wild type strain (data not shown) and showing that 373 
methionine biosynthesis is dispensable, when methionine can be taken up from the environment. 374 
The same was the case for the growth defects of the ΔmetH single mutant (μ= 0.35±0.03 with 375 
methionine supplied). When the metE gene was supplied in trans to the ΔmetE/ΔmetH double 376 
mutant, the growth was fully restored (μ= 0.24±0.03) to the level of the ΔmetH single mutant, 377 
showing the importance of the MetH enzyme during aerobic growth even with the MetE protein 378 
expressed from a multicopy plasmid. Addition of methionine to the ΔmetE mutant in M9 medium 379 
likewise raised the growth rate (μ= 0.20±0.01). A triple mutant, where the double metE/metH 380 
mutations were combined with mutation of purT did not grow in M9 media, corresponding to the 381 
phenotype of the ΔmetE/ΔmetH mutant on its own. Addition of methionine restored growth 382 
completely in this mutant (μ= 0.35±0.01), which also corresponded to the ΔmetE/ΔmetH mutant 383 
on its own. Taken together the results were interpreted as no or very little interaction between 384 
PurT and MetH/MetE, and vice versa. 385 
 386 
The ΔmetH mutant was slightly but significantly attenuated during mouse infection with a 387 
competitive index of 0.4 (p<0.001), while the ΔmetE single mutant and the ΔmetE/ΔmetH double 388 
mutants were totally avirulent (Table 3). Althougt the metE gene in trans fully complemented the 389 
growth phenotype of the double mutant to the level of the ΔmetE mutant in M9 medium, the 390 
presence of the metE gene on a multicopy gene did not render the double mutant virulent at all.  391 
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 Methionine appears to be available in macrophages to some extent, as the ΔmetE/ΔmetH double 392 
mutant could multiply three-fold within twenty hours in cultured macrophages (Table 4). While 393 
methionine is available in macrophages, we may conclude from the infection studies, that it is not 394 
available during other phases of mouse infection. Elimination of purT in the double mutant 395 
background reduced net multiplication rate in macrophages significantly (0.73±0.29), suggesting a 396 
synergistic effect of the mutations at this level. 397 
 398 
Discussion 399 
The main aim of this study was to determine the contribution of the in vivo redundant enzymes 400 
PurN and PurT to virulence in S. Typhimurium, and when realizing that they were not redundant in 401 
vivo during infection of mice, to elucidate possible reasons for this. In the broader perspective, the 402 
study illustrates that one cannot safely assume that in vitro redundancy between enzymes is 403 
followed by a similar in vivo redundancy during infection of mice. Another important observation, 404 
based on the in vitro growth experiments, is that even though E. coli and S. Typhimurium share 405 
the basic architecture of the metabolic systems we have investigated, the growth phenotypes 406 
associated with knock out of a gene cannot always be assumed to be the same. This notion has 407 
recently been highlighted in another publication, dealing with thiamine biosynthesis in E. coli (29).   408 
 409 
The concept of redundancy has mainly been understood from studies of E. coli K12. When it grows 410 
on glucose as the sole carbon source, more than 80 of the 227 metabolic enzymes are non-411 
essential (30). Redundancy may be a trade-off between efficiency and robustness, and organisms 412 
with a broad niche repertoire show the highest degree of redundancy. Therefore, redundancy has 413 
been interpreted as a mechanism that supports niche adaptation (31). Others, however, consider 414 
redundancy as a way to withstand detrimental mutations (32). Our observations with PurN and 415 
PurT, and MetE and MetH for that matter, suggest that some pairs of redundant enzymes may be 416 
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artefacts of studying bacteria in test tubes, and that the two enzymes are maintained because 417 
they are both essential, possibly at different steps in the normal live cycle (infection steps in the 418 
case of pathogenic bacteria). This corresponds mostly to the niche adaptation theory, since the 419 
likely explanation for both enzymes being essential is that Salmonella goes through a series of 420 
different environments (niches) in the infection process. However, in the niche adaptation theory, 421 
the need for both of the enzymes is not absolute. 422 
 423 
The total avirulence of both PurN and PurT mutants could be complemented by addition of the 424 
respective enzyme encoded from a plasmid in trans. This proved that the attenuation was related 425 
to the lack of the specific enzymes. It is well known that purine biosynthesis is required for 426 
intracellular multiplication, and purine biosynthesis mutants have been employed as live vaccines 427 
against S. Typhi (33) and S. Typhimurium (34), as well as Mycobacterium tuberculosis (35), 428 
Brucella melitensis (36) and Franscisella tularensis (37). In light of this it was not surprising that 429 
the double ΔpurN/ΔpurT mutant was attenuated and unable to multiply inside macrophages. 430 
However, previous studies on putative targets genes for attenuated life vaccines have ignored the 431 
3rd step in the biosynthesis of purines, catalysed by PurN and PurT, due to the recognized 432 
redundancy between the enzymes in vitro. Based on our results, deletion mutants in either PurN or 433 
PurT are likely also to be good vaccine candidates against Salmonella.  434 
 435 
Studies of multiplication ability in cultured macrophages is a sensitive method to identify virulence 436 
attenuation in Salmonella, and Leung and Finlay (38) showed that mutants that could not multiply 437 
in cultured macrophages were also avirulent in mice. The opposite, however, is not necessarily the 438 
case. The avirulent PurT mutant was not critically affected in propagation in the intracellular 439 
environment of J774A.1 macrophages. This suggested that the interaction with this cell type was 440 
not the limiting point for the PurT mutant. Contrary to the ΔpurT mutant, the ΔpurN mutant grew 441 
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poorly or was killed more quickly than wild type inside macrophages (these two things cannot be 442 
separated by the assay we used), suggesting that macrophage survival/growth could be one of the 443 
critical points in progression in the host for this mutant. Recent studies have shown that one 444 
should be careful not to over-interpret results from experiment with cultured macrophages, and 445 
especially not to draw conclusions on mechanism of virulence from such studies (39). Also it 446 
should be noted that the J774 cells have a different genetic background (BalB/c) than the 447 
mouse strain used, and even though they are both slr -/- (N-rampneg), this may make it difficult 448 
to compare the in vivo and the in vitro situation directly, Our results with macrophages should 449 
thus be interpreted with caution.  450 
 451 
Studies using a mutant in the essential S. Typhimurium purG gene (also termed purL) have shown 452 
that this purine auxotroph strain fail to repair DNA damage caused by Reactive Oxygen Species in 453 
the phagosome environment of the macrophage, and that this can explain the inability of the 454 
mutant to multiply inside macrophages (40). Our results suggest that PurN has sufficient activity 455 
within macrophages to ensure that DNA damage can be repaired in the absence of PurT, while 456 
PurT cannot ensure wild type propagation in macrophages in the absence of PurN. The reduction 457 
in net growth of the PurN mutant with approximately 50 % corresponds to previous observations 458 
on net growth rate of a ΔpurH mutant in mouse spleens (26). The results indicated that intra 459 
cellular propagation was the rate-limiting step causing attenuation of the purN mutant, and also 460 
that purines cannot be supplied in sufficient amounts from external sources during macrophage 461 
infection. A recent study has shown that the ΔpurH mutant grows with two distinct populations 462 
with respect to location and growth rate in the spleen of mice (26), probably reflecting that the 463 
growth happens in two compartments with two different demands for purine synthesis, and it 464 
would be interesting to investigate whether the ΔpurN mutant also grows as two separate 465 
populations inside macrophages.  466 
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 467 
Purine synthesis has been found to be marginally (down) regulated when S. Typhimurium grows 468 
inside cultured macrophages, and PurN and PurT are regulated to the same degree, although only 469 
PurN was significant different from the control by the statistical analysis used in the study (41). 470 
The reference condition was growth of opsonized bacteria in cell culture media, and the 471 
observation is therefore difficult to compare to the present study, where bacteria were grown in LB 472 
media prior to macrophage challenge; however, it indicates that S. Typhimurium requires as much 473 
or slightly more purine de novo biosynthesis to grow in cell culture medium as it requires for 474 
growing inside macrophages.  475 
 476 
With current techniques it is not possible to determine the exact amounts of important 477 
intermediates in the purine biosynthesis, such as THF species, in bacteria during infection. In order 478 
to understand why both enzymes were essential and whether this was related to imbalance on the 479 
consumption and production of THF species, we chose a mutant-based approach, where relevant 480 
genes were deleted in different combinations. Our studies with ΔpurU and ΔpurT strains strongly 481 
suggested that a main reason for attenuation of the purT mutant was accumulation of formate or 482 
wasteful use of fTHF by PurU, since the double ΔpurT/ΔpurU mutant was fully virulent. For this to 483 
make sense, the metabolism should be aerobic, since this is the condition where formate 484 
production by PurU is a dead end product in the absence of PurT (16). In this sense, our 485 
observation supports a recent study, showing that the environment perceived by Salmonella, when 486 
it resided in cells of the monocyte line in the spleen, is aerobic, because Salmonella exclusively 487 
resides in the red pulp in close proximity to erythrocytes (26). It still needs to be determined 488 
whether formate accumulation or wasteful fTHF, or both, are the important factor, and to detect 489 
the exact point in infection, where this may be the case. The fact that the mutant without PurT 490 
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could propagate in cultured macrophages suggested that formate accumulation and/or wasteful 491 
fTHF consumption is not a problem inside such cells. 492 
 493 
The current study also made important observations with regard to the role of C-1-metabolism in 494 
virulence. Based on in vitro experiments, the glycine cleavage enzyme, GCV, has been estimated 495 
to contribute less to formation of C-1 units in E. coli than the hydroxyl-methyltransferease-enzyme 496 
encoded by glyA (14). The growth experiments in the current study shows that S. Typhimurium in 497 
vitro shows the same balance between the two enzymes, since the ΔgcvT mutant was not growth 498 
attenuated, while the ΔglyA mutant did not grow. In vivo, however, the situation was totally 499 
opposite. The ΔglyA strain was only partly attenuated, while the ΔgcvT mutant was highly 500 
attenuated and colonies were rarely isolated from any infected animals. Interestingly, concurrent 501 
mutation in serA did not change this, which showed that contrary to previously expected (8), 502 
exogenous glycine, and not serine must be available to Salmonella during infection. Else, glycine 503 
and C-1 units could have been formed by glyA from serine, and then the ΔgcvT mutation would 504 
have had no effect (Figure 1B). When ΔpurN or ΔpurT mutations were combined with mutation of 505 
serA or glyA, the in vitro phenotypes indicated that the purine synthesis and C-1 metabolism 506 
systems did not interfere significantly with each other. Double mutants caused the same 507 
phenotype as the single gene with the highest influence on the performance of S. Typhimurium. 508 
Unexpectedly we discovered that ΔglyA mutants form elongated cells when growing in vitro. 509 
Filament formation is well known in Salmonella as a response to osmotic and cold stress (42,43), 510 
but this phenotype of glyA mutation has, to the best of the author’s knowledge, not previously 511 
been described in this genus, nor in any of its close relatives. The phenotype could be reversed by 512 
genetic complementation in trans, ruling out that it was caused by secondary mutations in genes 513 
of relevance for Z-ring formation.   514 
 515 
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In the process of detailing the link between the purine and methionine metabolism we discovered 516 
that the enzymes MetE/MetH, which are considered redundant (6) also did not show redundancy 517 
during infection. We confirmed that methionine is not taken up from the host during mice 518 
infection, since the ΔmetE/ΔmetH double mutant was avirulent. It has previously been shown that 519 
mutation of metC, which mobilises sulphur for methionine, is essential in S. Typhimurium (44), and 520 
S. Typhimurium is only one among several pathogens where methionine biosynthesis appears to 521 
be essential during growth in the animal host (45,46). In vitro, the double mutant did not grow 522 
either. This phenotype could be complemented by addition of methionine to the medium, showing 523 
that the methionine uptake system can compensate fully for lack of the biosynthesis system during 524 
growth in vitro. Provision of metE in trans  restored growth to the level of the ΔmetH mutant.  This 525 
demonstrated that the metE mutation can be complemented in trans and that MetE and MetH are 526 
not fully redundant;  the enzyme MetH, which is associated to anaerobic growth (26), must play a 527 
role during this growth, even though the cultures were shaken. Further studies are needed to fully 528 
understand the reasons for this observation. Like for the C-1 metabolism, we did not find any 529 
indication that purine mutation significantly affected the phenotypes obtained after mutation of 530 
methionine synthesis genes.  531 
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Table 1. Strains and plasmids used in the study. 679 
 680 
Strain number Strain Genotype and 
marker# 
Source 
Jeo3774 S. Typhimurium 4/74 Wild- type (47) 
Jeo1473 S. Typhimurium 
ΔpurN::Cm 
4/47 
ΔSTM474_2603, cmr 
This study 
Jeo1516 S. Typhimurium 
ΔpurN::Cm-comp. 
4/47 
ΔSTM474_2603+ 
STM474_2603comp, 
cmr, ampr 
This study 
Jeo1496 S. Typhimurium 
ΔpurT::Kan 
4/47 
ΔSTM474_1915, 
kanr 
This study 
Jeo1517 S. Typhimurium 
ΔpurT::Kan-comp. 
4/47 
ΔSTM474_1915+ 
STM474_1915comp, 
kanr, ampr 
This study 
Jeo1509 S. Typhimurium 
ΔpurN::Cm/ ΔpurT::Kan 
4/74 
ΔSTM474_2603/ 
ΔSTM474_1915, 
kanr, cmr 
This study 
Jeo1512 S. Typhimurium 
ΔglyA::Kan 
4/47 
ΔSTM474_2659, 
kanr 
(8) 
Jeo1528 S. Typhimurium 4/47 This study 
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ΔglyA::Cm ΔSTM474_2659, cmr 
Jeo1570 S. Typhimurium 
ΔglyA::Kan- comp. 
4/47 ΔSTM474_2659 
+ STM474_2659comp, 
kanr, ampr 
This study 
Jeo1526 S. Typhimurium 
ΔserA::Kan 
4/47 
ΔSTM474_3209, 
kanr 
This study 
Jeo1514 S. Typhimurium 
ΔserA::Kan/ ΔglyA::Cm 
4/47 ΔSTM474_3209 
+ ΔSTM474_2659  
kanr, cmr 
This study 
Jeo1527 S. Typhimurium 
ΔpurT::kan/ ΔglyA::cm 
4/74 
ΔSTM474_1915/ 
ΔSTM474_2659, 
kanr, cmr  
This study 
Jeo1522 S. Typhimurium 
ΔpurT::kan/ ΔserA::cam
4/74 
ΔSTM474_1915/ 
ΔSTM474_3209, 
kanr, cmr  
This study 
Jeo1521 S. Typhimurium 
ΔpurN::Kan/ ΔglyA::Cm 
4/74 
ΔSTM474_2603/ 
ΔSTM474_2659, 
kanr, cmr  
This study 
Jeo1525 S. Typhimurium 
ΔpurN::Kan/ ΔserA::Cm 
4/74 
ΔSTM474_2603/ 
ΔSTM474_3209, 
This study 
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kanr, cmr  
Jeo1523 S. Typhimurium 
ΔpurU::Kan 
4/47 
ΔSTM474_1773, 
kanr 
This study 
Jeo1577 S. Typhimurium ΔpurU -
compl 
4/47 
ΔSTM474_1773+ 
ΔSTM474_1773compl, 
ampr 
This study 
Jeo1572 S. Typhimurium ΔpurU 
/ΔpurT::kan 
4/47 
ΔSTM474_1773, 
ΔSTM474_1915, 
kanr 
This study 
Jeo1529 S. Typhimurium 
ΔgcvT::Cm 
4/47 
ΔSTM474_3202, cmr 
This study 
Jeo1531 S. Typhimurium 
ΔserA::Kan/ ΔgcvT::Cm 
4/74 
ΔSTM474_3209/ 
ΔSTM474_3202, 
kanr, cmr  
This study 
Jeo1530 S. Typhimurium 
ΔglyA::Kan/ ΔgcvT::Cm 
4/74 
ΔSTM474_2659/ 
ΔSTM474_3202, 
kanr, cmr  
This study 
Jeo1574 S. Typhimurium 
ΔmetE::Kan 
4/47 
ΔSTM474_4143, 
kanr 
This study 
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Jeo1590 S. Typhimurium 
ΔmetH::Cm 
4/47 
ΔSTM474_4378, Cmr 
This study 
Jeo1593 S. Typhimurium 
ΔmetE::Kan/ 
ΔmetH::Cm 
4/74 
ΔSTM474_4143/ 
ΔSTM474_4378, 
kanr, cmr  
This study 
Jeo1599 S. Typhimurium 
ΔmetE::Kan/ 
ΔmetH::Cm-comp. 
4/74 
ΔSTM474_4143/ 
ΔSTM474_4378/+ 
STM474_4143comp 
This study 
Jeo1594 S. Typhimurium 
ΔmetE::Kan/ 
ΔmetH::Cm, 
ΔpurT::Kan 
4/74 
ΔSTM474_4143/ 
ΔSTM474_4378/ 
ΔSTM474_1915, 
kanr, cmr  
This study 
- S. Typhimurium 
ΔssaV::Kan 
4/47 
ΔSTM474_1420, 
kanr 
(21) 
- pKD3 Template plasmid 
for amplification of 
chloramphenicol 
resistance gene 
cassette. Ampr, Cmr 
(20) 
- pKD4 Template plasmid 
for amplification of 
(20) 
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kanamycin 
resistance gene 
cassette. Ampr, Kanr 
- pKD46 Lambda red 
mediated 
recombination 
system. Ampr 
(20) 
- pACYC177 Low copy number 
plasmid used for 
complementation. 
Ampr. 
(48) 
*Gene numbers refer to the 4/74 genome annotation in BioCyC (www.biocyc.org). Cmr: 681 
chloramphenicol resistant through insertion of the chloramphenicol gene cassette from the plasmid 682 
pKD3. Kanr: Kanamycin resistant through the insertion of the kanamycin resistance gene cassette 683 
from the plasmid pKD4. Comp: Complemented in trans by cloning of the deleted gene on the 684 
plasmid pACY177. 685 
  686 
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Table 2. Growth and Virulence of S. Typhimurium 4/74 pur-mutants. 687 
 Strain  Mutant Growth ratea,b 
(μ, hours-1)) 
 Mice 
virulence 
 (2)b 
J774A.1 macrophagec 
(multiplication/20 h)b 
 Jeo3774  WT 4/74 0.37±0.017  1.00 9.7 ± 2.5 
 Jeo1473  ∆purN 0.35±0.01  0.03 ± 
0.0*** 
4.4 ± 3.5* 
 Jeo1516  ∆purN / pACYC177purN 0.31±0.08  0.60 ± 0.2 ND 
 Jeo1496  ∆purT 0.36±0.02  0.02 0.01*** 8.0 ± 5.6 
 Jeo1517  ∆purT / pACYC177purT 0.37±0.01  0.90 ± 0.3 ND 
 Jeo1509  ∆purN / ∆purT NG  0.00 ± 
0.0NT 
0.3 ± 0.2**** 
 Jeo1523  ∆purU 0.25±0.002***  0.60 ± 0.8 4.6 ± 2.5* 
 Jeo1575  ∆purU / pACYC177purU 0.15±0.002***  ND 2.1 ± 0.1* 
 Jeo1572  ∆purU / ∆purT 0.38±0.01  1.63 ± 
0.6**  
ND 
ND: not determined; NG: no growth in M9 + glucose medium. 688 
a: Specific growth rate in vitro in M9+glucose (ln(2)/doubling time).  689 
b: *: p<0.05;  **: P-value <0.01 ***: p-value <0.001; ****: p<0.0001; NT: Cannot be tested as 690 
no mutant colonies were recovered from challenged mice. 691 
c: Control 4/74 ∆ssaV: 2.1 ± 0.6*** 692 
  693 
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Table 3. Growth and virulence phenotypes of mutants in glycine and serine metabolism 694 
in S. Typhimurium 4/74. 695 
Strain Genotype Growth ratea,b
(μ,  hours-1) 
Mice virulence 
(2) 
Macrophage 
multiplication 
(1h to 21 h)c 
Jeo3774 Wildtype (WT) 4/74 0.37±0.017 1.00 6.9 ± 3.4 
Jeo1529 ∆gcvT 0.36±0.002 0.03 ± 0.03***e 7.2 ± 3.9 
Jeo1531 ∆serA ∆gcvT  ND 0.05 ± 0.04*** ND 
Jeo1522 ∆serA ∆purT NG 0.15 ± 0.15***  ND 
Jeo1512 ∆glyA 0.03±0.003 0.3 ± 0.4* 0.3 ± 0.03**
Jeo1512 ∆glyA+glyd 0.20±0.01 NR NR 
Jeo1570 ∆glyA+pACYC177glyA 0.35±0.01 ND 5.6 ± 1.50e
Jeo1514 ∆glyA ∆serA  NG 0.01 ± 0.01*** ND 
Jeo1530 ∆glyA ∆gcvT  NG 0.0 ± 0.0NT(*) ND 
Jeo1521 ∆glyA ∆purN 0.03±0.003 0.02 ± 0.02*** 1.2 ± 1.0***
ND: not done; NG: no growth in M9 + glucose medium. 696 
a: Specific growth rate in vitro in M9+glucose (ln(2)/doubling time).  697 
b: *: p<0.05;  **: P-value <0.01 ***: p-value <0.001; ****: p<0.0001;  698 
NT: This strain could not be tested statisically as no mutant colonies were recovered from 699 
challenged mice. If for statistical purposes, one assumed one colony to be obtained from each 700 
mouse of this double mutant, the results would not have been significantly different from the 701 
competitive index of the ∆gcvT mutant on its own (p=0.06) but significantly different from the 702 
glyA mutant (p=0.03). 703 
c: Control 4/74 ∆ssaV: 2.1 ± 0.6*** 704 
d: Growth in M9 minimal medium with supplement of glycine (gly). 705 
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e: Multiplication rate is significantly different from Jeo1512 (∆glyA) and not different from Jeo3774 706 
(wild type strain). 707 
  708 
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Table 4. Virulence phenotypes of metE and metH mutants in S. Typhimurium 4/74. 709 
Strain number Genotype Growth 
ratea,b 
(μ) gene/h 
Competitive 
index (2) 
Multiplication 
rate in 
macrophages 
(1h to 21 h)d 
Jeo3774 Wildtype (WT) 4/74c 0.37±0.02 1.00 6.9 ± 3.4 
Jeo1590 ∆metH 0.20±0.01 0.4 ± 0.2 ND 
Jeo1590 ∆metH+metc 0.33±0.03 NR NR 
Jeo1574 ∆metE 0.06±0.01 0.0 ± 0.0 ND 
Jeo1574 ∆metE+metc 0.23±0.05 NR NR 
Jeo1593 ∆metH ΔmetE NG 0.0 ± 0.0NT 2.9 ± 0,4 
Jeo1593 ∆metH ΔmetE+metc 0.26±0.005 NR NR 
Jeo1599 ∆metH ΔmetE 
/pAYCY177metE 
0.24±0.002 0.00 ± 
0.0NT 
ND 
ND: not done; NG: no growth in M9 + glucose medium. 710 
a: growth rate in vitro in M9+glucose.  711 
b: *: p<0.05;  **: P-value <0.01 ***: p-value <0.001; ****: p<0.0001; NT: Cannot be tested as 712 
no mutant colonies were recovered from challenged mice. 713 
c: Growth in M9 minimal medium with supplement of methionine 714 
d: Control 4/74 ∆ssaV: 2.1 ± 0.6*** 715 
  716 
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Fig 1. The third reaction-step in the purine de novo synthesis carried out by the in vitro redundant 717 
enzymes PurN and PurT (Fig. 1A), and the interconnection between purine synthesis and the 718 
carbon-1 metabolism, where essential carbon-1 (C-1) units are produced (Fig 1B).  719 
(Fig 1A): PurN converts Gar to fGar using fTHF as formyl donor, while PurT converts Gar to fGar 720 
using formate as formyl donor. Formate is produced from fTHF by the enzyme PurU. (B): The 721 
production of C-1 units for amino acid and purine synthesis in S. Typhimurium happens when GlyA 722 
converts serine into glycine and when glycine is converted into ammonia and carbon dioxide by 723 
the glycine cleavage system. The pools of formyl-THF (fTHF), THF and methylene-THF (mTHF) are 724 
shared between the purine and the Carbon-1 synthesis pathways. 725 
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